Skip to main content

Advertisement

SpringerLink
Log in

Interventions for Pediatric Renovascular Hypertension

  • Pediatric Hypertension (JT Flynn, Section Editor)
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Renovascular disease is a cause of hypertension in 10 % to 15 % of prepubertal children. Interventions to address hypertension and causes of renovascular disease continue to advance. Successful interventions to treat renovascular disease include medical, angiographic, and surgical means, used alone or, more often, as combination therapy. Medical therapy is used to control the blood pressure prior to further intervention or in specific instances as long-term single therapy. Judicious use of percutaneous angioplasty and surgical intervention is usually successful in children with renal artery stenosis, although up to two-thirds of children will remain on antihypertensive medication after the procedure. Outcomes of combination therapy will continue to improve with advances in the use of antihypertensive medication in children, improvements in percutaneous angiography techniques, and progress in vascular surgical expertise.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Ghabril R. Renovascular hypertension in children. J Med Liban. 2010;58(3):146–8.

    PubMed  Google Scholar 

  2. Grinsell MM, Norwood VF. At the bottom of the differential diagnosis list: unusual causes of pediatric hypertension. Pediatr Nephrol. 2009;24(11):2137–46.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Brady TM, Feld LG. Pediatric approach to hypertension. Semin Nephrol. 2009;29(4):379–88.

    Article  PubMed  Google Scholar 

  4. Kanitkar M. Renovascular hypertension. Indian Pediatr. 2005;42(1):47–54.

    CAS  PubMed  Google Scholar 

  5. Sethna CB, Kaplan BS, Cahill AM, Velazquez OC, Meyers KE. Idiopathic mid-aortic syndrome in children. Pediatr Nephrol. 2008;23(7):1135–42. This study presents a comprehensive review of the clinical presentation and management of 102 pediatric cases of mid-aortic syndrome (MAS).

    Article  PubMed  Google Scholar 

  6. Marks SD, Tullus K. Do classification criteria of Takayasu arteritis misdiagnose children with fibromuscular dysplasia? Pediatr Nephrol. 2010;25(5):989–90 author reply 991-982. This study presents a comprehensive review of the clinical presentation and management of 102 pediatric cases of mid-aortic syndrome (MAS).

  7. Tullus K. Renovascular hypertension—is it fibromuscular dysplasia or Takayasu arteritis. Pediatr Nephrol. 2013;28(2):191–6. This paper discusses the importance of an accurate diagnosis of the cause of RVHTN in children and how an accurate diagnosis will influence treatment of the RVHTN..

    Article  PubMed  Google Scholar 

  8. Safak E, Wilke C, Derer W, et al. Long-term follow-up of patients with atherosclerotic renal artery disease. J Am Soc Hypertens. 2013;7(1):24–31.

    Article  PubMed  Google Scholar 

  9. Ribichini F, Pighi M, Zivelonghi C, et al. Invasive assessment of renal artery atherosclerotic disease and resistant hypertension before renal sympathetic denervation. J Nephrol. 2013;26(4):799–801. This paper discusses the use of intravascular ultrasound (IVUS), and measurement of the translesional pressure gradient in RAS, techniques that are in the process of being introduced to pediatric care.

    Article  PubMed  Google Scholar 

  10. Cianci R, Zuccala A, Lucisano G, et al. Have we new therapeutic strategies in the treatment of renovascular nephropathy? Curr Vasc Pharmacol. 2013;11(4):531–42. This review of the literature evaluates current pharmacological and endovascular treatment of atherosclerotic RAS and ischemic nephropathy.

    Article  CAS  PubMed  Google Scholar 

  11. Flynn JT, Tullus K. Severe hypertension in children and adolescents: pathophysiology and treatment. Pediatr Nephrol. 2009;24(6):1101–12.

    Article  PubMed  Google Scholar 

  12. Tullus K, Brennan E, Hamilton G, et al. Renovascular hypertension in children. Lancet. 2008;371(9622):1453–63. This study demonstrates that RVHTN in children is best managed by a multidisciplinary team consisting of pediatric nephrologists, interventional radiologists, and vascular surgeons.

    Article  CAS  PubMed  Google Scholar 

  13. Seeman T, Dostalek L, Gilik J. Control of hypertension in treated children and its association with target organ damage. Am J Hypertens. 2012;25(3):389–95. This study on BP control in hypertensive children illustrates the importance of using ABPM to assess control of HTN in children with treated RAS.

    Article  CAS  PubMed  Google Scholar 

  14. O’Neill Jr JA, Berkowitz H, Fellows KJ, Harmon CM. Midaortic syndrome and hypertension in childhood. J Pediatr Surg. 1995;30(2):164–71 discussion 171-162. This study presents a comprehensive review of the clinical presentation and management of 102 pediatric cases of mid-aortic syndrome (MAS).

  15. Panayiotopoulos YP, Tyrrell MR, Koffman G, Reidy JF, Haycock GB, Taylor PR. Mid-aortic syndrome presenting in childhood. Br J Surg. 1996;83(2):235–40.

    Article  CAS  PubMed  Google Scholar 

  16. Tummolo A, Marks SD, Stadermann M, et al. Mid-aortic syndrome: long-term outcome of 36 children. Pediatr Nephrol. 2009;24(11):2225–32.

    Article  PubMed  Google Scholar 

  17. Nasser H, Nehme GD, Dumitriu D, et al. Idiopathic midaortic syndrome: normalization of blood pressure on medication. Pediatr Nephrol. 2012;27(2):313–6. In the absence of renal dysfunction or target-organ damage, medical management of hypertension in MAS is feasible without intervention if blood pressure is well-controlled on two antihypertensive agents.

    Article  PubMed  Google Scholar 

  18. Stanley JC, Criado E, Upchurch Jr GR, et al. Pediatric renovascular hypertension: 132 primary and 30 secondary operations in 97 children. J Vasc Surg. 2006;44(6):1219–28. This retrospective analysis is of 39 girls and 58 boys treated by operation for RAS from 1963 to 2006; surgery benefited 97% of these children. discussion 1228-1219.

    Article  PubMed  Google Scholar 

  19. Tullus K, Roebuck DJ, McLaren CA, Marks SD. Imaging in the evaluation of renovascular disease. Pediatr Nephrol. 2010;25(6):1049–56. Renovascular disease (RVD) is an important cause of HTN in children. Doppler US, CTA, and MRA can all be helpful, but none at present has high enough sensitivity to rule out RVD.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Shroff R, Roebuck DJ, Gordon I, et al. Angioplasty for renovascular hypertension in children: 20 year experience. Pediatrics. 2006;118(1):268–75.

    Article  PubMed  Google Scholar 

  21. Srinivasan A, Krishnamurthy G, Fontalvo-Herazo L, et al. Spectrum of renal findings in pediatric fibromuscular dysplasia and neurofibromatosis type 1. Pediatr Radiol. 2011;41(3):308–16. This paper gives a descriptive characterization of 68 renal angiograms performed over 11 years on 43 children with FMD and NF1. It characterizes lesion site, extent, and association with mid-aortic stenosis.

    Article  PubMed  Google Scholar 

  22. Lurbe E, Cifkova R, Cruickshank JK, et al. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens. 2009;27(9):1719–42.

    Article  CAS  PubMed  Google Scholar 

  23. Tobias JD, Tulman DB, Bergese SD. Clevidipine for perioperative blood pressure control in infants and children. Pharmaceuticals (Basel). 2013;6(1):70–84.

    Article  CAS  Google Scholar 

  24. Dionne JM, Abitbol CL, Flynn JT. Hypertension in infancy: diagnosis, management and outcome. Pediatr Nephrol. 2012;27(1):17–32. This review gives important updates and advice on the diagnoisis, evaluation, management, and outcome of hypertension in the neonate and older infant.

    Article  PubMed  Google Scholar 

  25. Cohen M. What is the normal serum creatinine concentration in children? Pediatr Radiol. 2008;38(11):1265 author reply 1266.This study presents a comprehensive review of the clinical presentation and management of 102 pediatric cases of mid-aortic syndrome (MAS).

  26. Schwartz GJ, Haycock GB, Edelmann Jr CM, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976;58(2):259–63.

    CAS  PubMed  Google Scholar 

  27. Schwartz GJ, Haycock GB, Spitzer A. Plasma creatinine and urea concentration in children: normal values for age and sex. J Pediatr. 1976;88(5):828–30.

    Article  CAS  PubMed  Google Scholar 

  28. Schwartz GJ, Abraham AG, Furth SL, Warady BA, Munoz A. Optimizing iohexol plasma disappearance curves to measure the glomerular filtration rate in children with chronic kidney disease. Kidney Int. 2010;77(1):65–71.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Goonasekera CD, Shah V, Wade AM, Dillon MJ. The usefulness of renal vein renin studies in hypertensive children: a 25 years experience. Pediatr Nephrol. 2002;17(11):943–9.

    Article  PubMed  Google Scholar 

  30. Roebuck DJ, Vendhan K, Barnacle AM, Brew S, McLaren CA. Ultrasound-guided transaxillary access for diagnostic and interventional arteriography in children. J Vasc Interv Radiol. 2010;21(6):842–7. Most pediatric arteriograms are obtained using a femoral approach, although alternative access sites are sometimes needed. This paper describes the feasibility of ultrasound-guided transaxillary access for arteriography in children when femoral access is impossible or unfavorable for technical reasons.

    Article  PubMed  Google Scholar 

  31. Heran MK, Marshalleck F, Temple M, et al. Joint quality improvement guidelines for pediatric arterial access and arteriography: from the Societies of Interventional Radiology and Pediatric Radiology. J Vasc Interv Radiol. 2010;21(1):32–43.

    Article  PubMed  Google Scholar 

  32. Marshalleck F. Pediatric arterial interventions. Tech Vasc Interv Radiol. 2010;13(4):238–43. This paper discusses the special considerations that need to be taken in children, including the use of appropriate equipment, appropriate dosing of contrast, and use of various medications required during angiography, particularly in patients less than 15 kg in weight.

    Article  PubMed  Google Scholar 

  33. Srinivasan A, Krishnamurthy G, Fontalvo-Herazo L, et al. Angioplasty for renal artery stenosis in pediatric patients: an 11 years retrospective experience. J Vasc Interv Radiol. 2010;21(11):1672–80. This study characterizes the utility of pediatric renal angioplasty in children with FMD and NF1 and suggests criteria that may be prognostic of patient vascular response.

    Article  PubMed  Google Scholar 

  34. Towbin RB, Pelchovitz DJ, Cahill AM, et al. Cutting balloon angioplasty in children with resistant renal artery stenosis. J Vasc Interv Radiol. 2007;18(5):663–9. This study presents a comprehensive review of the clinical presentation and management of 102 pediatric cases of mid-aortic syndrome (MAS).

  35. Tyagi S, Kaul UA, Satsangi DK, Arora R. Percutaneous transluminal angioplasty for renovascular hypertension in children: initial and long-term results. Pediatrics. 1997;99(1):44–9.

    Article  CAS  PubMed  Google Scholar 

  36. Mali WP, Puijlaert CB, Kouwenberg HJ, et al. Percutaneous transluminal renal angioplasty in children and adolescents. Radiology. 1987;165(2):391–4.

    CAS  PubMed  Google Scholar 

  37. Tanaka R, Higashi M, Naito H. Angioplasty for non-arteriosclerotic renal artery stenosis: the efficacy of cutting balloon angioplasty versus conventional angioplasty. Cardiovasc Intervent Radiol. 2007;30(4):601–6.

    Article  PubMed  Google Scholar 

  38. Tanemoto M, Abe T, Chaki T, Satoh F, Ishibashi T, Ito S. Cutting balloon angioplasty of resistant renal artery stenosis caused by fibromuscular dysplasia. J Vasc Surg. 2005;41(5):898–901.

    Article  PubMed  Google Scholar 

  39. Haas NA, Ocker V, Knirsch W, et al. Successful management of a resistant renal artery stenosis in a child using a 4 mm cutting balloon catheter. Catheter Cardiovasc Interv. 2002;56(2):227–31.

    Article  PubMed  Google Scholar 

  40. Dworkin LD, Cooper CJ. Clinical practice. Renal-artery stenosis. N Engl J Med. 2009;361(20):1972–8.

    Article  CAS  PubMed  Google Scholar 

  41. Sapoval M, Tamari I, Goffette P, et al. 1 year clinical outcomes of renal artery stenting: the results of ODORI Registry. Cardiovasc Intervent Radiol. 2010;33(3):475–83. This study presents a comprehensive review of the clinical presentation and management of 102 pediatric cases of mid-aortic syndrome (MAS).

  42. McLaren CA, Roebuck DJ. Interventional radiology for renovascular hypertension in children. Tech Vasc Interv Radiol. 2003;6(4):150–7.

    Article  PubMed  Google Scholar 

  43. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med. 2004;350(18):1862–71.

    Article  CAS  PubMed  Google Scholar 

  44. Cluzel P, Raynaud A, Beyssen B, Pagny JY, Gaux JC. Stenoses of renal branch arteries in fibromuscular dysplasia: results of percutaneous transluminal angioplasty. Radiology. 1994;193(1):227–32.

    CAS  PubMed  Google Scholar 

  45. Klow NE, Paulsen D, Vatne K, Rokstad B, Lien B, Fauchald P. Percutaneous transluminal renal artery angioplasty using the coaxial technique. 10 years of experience from 591 procedures in 419 patients. Acta Radiol. 1998;39(6):594–603.

    Article  CAS  PubMed  Google Scholar 

  46. Kim HJ, Do YS, Shin SW, et al. Percutaneous transluminal angioplasty of renal artery fibromuscular dysplasia: mid-term results. Korean J Radiol. 2008;9(1):38–44.

    Article  PubMed Central  PubMed  Google Scholar 

  47. Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia. J Vasc Surg. 2008;48(4):865–71.

    Article  PubMed  Google Scholar 

  48. Dillon MJ. The diagnosis of renovascular disease. Pediatr Nephrol. 1997;11(3):366–72.

    Article  CAS  PubMed  Google Scholar 

  49. Huang Y, Duncan AA, McKusick MA, et al. Renal artery intervention in pediatric and adolescent patients: a 20 years experience. Vasc Endovascular Surg. 2007;41(6):490–9.

    Article  PubMed  Google Scholar 

  50. Stanley JC. Surgical intervention in pediatric renovascular hypertension. Child Nephrol Urol. 1992;12(2–3):167–74.

    CAS  PubMed  Google Scholar 

  51. Lacombe M, Ricco JB. Surgical revascularization of renal artery after complicated or failed percutaneous transluminal renal angioplasty. J Vasc Surg. 2006;44(3):537–44.

    Article  PubMed  Google Scholar 

  52. Lacombe M. Surgical treatment of renovascular hypertension in children. Eur J Vasc Endovasc Surg. 2011;41(6):770–7. This study presents a comprehensive review of the clinical presentation and management of 102 pediatric cases of mid-aortic syndrome (MAS).

  53. O’Neill Jr JA. Long-term outcome with surgical treatment of renovascular hypertension. J Pediatr Surg. 1998;33(1):106–11.

    Article  PubMed  Google Scholar 

  54. Stanley JC, Ernst CB, Fry WJ. Fate of 100 aortorenal vein grafts: characteristics of late graft expansion, aneurysmal dilatation, and stenosis. Surgery. 1973;74(6):931–44.

    CAS  PubMed  Google Scholar 

  55. Stanley JC, Fry WJ. Pediatric renal artery occlusive disease and renovascular hypertension. Etiology, diagnosis, and operative treatment. Arch Surg. 1981;116(5):669–76.

    Article  CAS  PubMed  Google Scholar 

  56. Martinez A, Novick AC, Cunningham R, Goormastic M. Improved results of vascular reconstruction in pediatric and young adult patients with renovascular hypertension. J Urol. 1990;144(3):717–20.

    CAS  PubMed  Google Scholar 

  57. Stadermann MB, Montini G, Hamilton G, et al. Results of surgical treatment for renovascular hypertension in children: 30 years single centre experience. Nephrol Dial Transplant. 2010;25(3):807–13.

    Article  PubMed  Google Scholar 

  58. Bleacher J, Turner ME, Quivers E, Schwartz MZ. Renal autotransplantation for renovascular hypertension caused by midaortic syndrome. J Pediatr Surg. 1997;32(2):248–50. This study presents a comprehensive review of the clinical presentation and management of 102 pediatric cases of mid-aortic syndrome (MAS).

  59. Corbetta JP, Duran V, Burek C, et al. Renal autotransplantation for the treatment of renovascular hypertension in the pediatric population. J Pediatr Urol. 2011;7(3):378–82. This study presents a comprehensive review of the clinical presentation and management of 102 pediatric cases of mid-aortic syndrome (MAS).

  60. Messina LM, Reilly LM, Goldstone J, Ehrenfeld WK, Ferrell LD, Stoney RJ. Middle aortic syndrome. Effectiveness and durability of complex arterial revascularization techniques. Ann Surg. 1986;204(3):331–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  61. Poulias GE, Skoutas B, Doundoulakis N, et al. The mid-aortic dysplastic syndrome. Surgical considerations with a 2 to 18 years follow-up and selective histopathological study. Eur J Vasc Surg. 1990;4(1):75–82.

    Article  CAS  PubMed  Google Scholar 

  62. Robicsek F, Daugherty HK, Cook JW, Cafoncelli A. Coarctation of the abdominal aorta with stricture of the major vessels. Surgery. 1980;87(5):545–8.

    CAS  PubMed  Google Scholar 

  63. Hallett Jr JW, Brewster DC, Darling RC, O’Hara PJ. Coarctation of the abdominal aorta: current options in surgical management. Ann Surg. 1980;191(4):430–7.

    Article  PubMed Central  PubMed  Google Scholar 

  64. Kimura H, Sato O, Deguchi JO, Miyata T. Surgical treatment and long-term outcome of renovascular hypertension in children and adolescents. Eur J Vasc Endovasc Surg. 2010;39(6):731–7. This study presents a comprehensive review of the clinical presentation and management of 102 pediatric cases of mid-aortic syndrome (MAS).

  65. Piercy KT, Hundley JC, Stafford JM, et al. Renovascular disease in children and adolescents. J Vasc Surg. 2005;41(6):973–82.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

ᅟ

Conflict of Interest

Kevin E. Meyers, Anne Marie Cahill, and Christine B. Sethna declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Department of Pediatrics, The Children’s Hospital of Philadelphia and University of Pennsylvania, 1st Floor, Main Building, Cnr 34th Street and Civic Center Boulevard, Philadelphia, PA, 19026, USA

    Kevin E. Meyers

  2. Department of Radiology, The Children’s Hospital of Philadelphia and University of Pennsylvania, 3rd Floor, Main Building, Cnr 34th Street and Civic Center Boulevard, Philadelphia, PA, 19026, USA

    Anne Marie Cahill

  3. Department of Pediatrics, Cohen Children’s Medical Center of New York, 269-01 76th Avenue, New Hyde Park, NY, 11040, USA

    Christine Sethna

Authors
  1. Kevin E. Meyers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne Marie Cahill
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christine Sethna
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kevin E. Meyers.

Additional information

This article is part of the Topical Collection on Pediatric Hypertension

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meyers, K.E., Cahill, A.M. & Sethna, C. Interventions for Pediatric Renovascular Hypertension. Curr Hypertens Rep 16, 422 (2014). https://doi.org/10.1007/s11906-014-0422-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11906-014-0422-3

Keywords

Search

Navigation